November 1, 2022 Reading Time: 2 minutes
Reprinted from the Independent Institute

Covid-19 is likely endemic and will remain with us for the foreseeable future. Fortunately, it is also becoming milder. Some medical research argues that current dominant variants are less deadly than the flu. Hospitalizations have also steeply declined in recent weeks.

Regardless, President Biden recently announced he is extending the Covid-19 public health emergency for another 90 days. This will place the country under a public health emergency for Covid into early 2023. The U.S. is also under a public health state of emergency for monkeypox. 

This comes at a surprising time. On October 21st, there were about 7,100 new Covid-19 cases. Ten months prior, data collectors at Johns Hopkins University reported over 1 million new Covid-19 cases. This reduction occurred despite Covid’s continual mutation into more contagious variants and dramatically curtailing of recommended public health guidelines to prevent disease spread.

So why extend the state of emergency? Sadly, the answer likely has more to do with power than public health. 

In Robert Higgs’ masterful book Crisis and Leviathan, he explains that governments rapidly expand their size and power during crises. Through a mechanism called the ratchet effect, governments rarely return to their pre-crisis size and often retain their newly granted powers. Higgs’ chilling conclusion is that government growth allowed by a concerned public to end a crisis far outlasts the actual crisis.

One of the simplest ways for a state to expand and extend its control during a crisis is to extend the crisis—even when it is unwarranted. Government responses to Covid-19 provide one of the clearest losses of liberty in recent memory. As Economist Benjamin Powell writes in Real Clear Markets, “U.S. economic freedom fell 3.5 percent in 2020–to its lowest level since 1975.” 

Many of these losses to our freedom show signs of becoming permanent. Consider:

  • Student loan payment moratoriums have been extended continuously since 2020. Most public discourse has transitioned from when to resume payment to how much to forgive. 
  • The emergency use authorization process for medical goods transformed from a “test now, approve later” approach in early 2020 into a way to grant favors to politically connected drug producers.
  • According to the Committee for a Responsible Federal Budget, the federal government has authorized about $14.1 trillion in Covid-related spending. Most recent estimates indicate only 11 trillion has been spent, with most remaining funds categorized as “administrative.” 
  • When Covid-19 vaccines became available, the government assumed an unprecedented role in distributing vital medical goods across the country. Without significant pushback, it took the same position in distributing monkeypox vaccines (and failed just as spectacularly). 
  • President Biden has signed 102 executive orders since taking office. President Trump signed 74 in the last year of his Presidency. The previous two Presidents signed 276 and 291 over both terms

Governments tasked with deciding when to end a crisis have ample opportunities to expand their influence. The Biden Administration granted itself three more months to prolong and extend the ratchet effect to secure more power and less freedom. Tragically, the longer government extends the crisis, the less likely they are to relinquish control.

Raymond J. March


Raymond March is a faculty fellow at the NDSU Center for the Study of Public Choice and Private Enterprise (PCPE) an assistant professor in the NDSU Department of Agribusiness and Applied Economics, a fellow with the AIER Public Choice and Public Policy Project, and a contributor to Young Voices. His research has appeared in the Southern Economic Journal,  Public ChoiceJournal of Institutional Economics, and Research Policy. He has published articles in National InterestWashington TimesWashington ExaminerThe HillRealClearHealth, and elsewhere.

Raymond is a research fellow at the Independent Institute and the director of, an educational research and communications project on the U.S. Food and Drug Administration (FDA).

Get notified of new articles from Raymond J. March and AIER.